India’s CRDMO sector growth potential at $22 - $25 Billion by 2035: BCG-IPSO Report
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Ibuprofen and famotidine combination is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
Consolidated manufacturing volumes for Q3 FY25 remained stable at 132,187 KL, while for 9M FY25 it stood at 372,505 KL
The company is committed to revolutionizing API development by advancing synthesis and analytical processes that enhance quality and impact lives
It will bring together renowned global experts in the field to discuss groundbreaking advances in biomaterials and their clinical applications
Subscribe To Our Newsletter & Stay Updated